Cytokine storm

DC Fajgenbaum, CH June - New England Journal of Medicine, 2020 - Mass Medical Soc
Cytokine Storm Cytokine storm, a life-threatening disorder involving cytokine elevations and
immune-cell hyperactivation, has various causes and is characterized by constitutional …

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

P La Rosée, AC Horne, M Hines… - Blood, The Journal …, 2019 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome
induced by aberrantly activated macrophages and cytotoxic T cells. The primary (genetic) …

Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline

BD Santomasso, LJ Nastoupil, S Adkins… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To increase awareness, outline strategies, and offer guidance on the
recommended management of immune-related adverse events (irAEs) in patients treated …

[HTML][HTML] Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome

MR Hines, TE Knight, KO McNerney, MB Leick… - … and Cellular Therapy, 2023 - Elsevier
Background T cell mediated hyperinflammatory responses such as cytokine release
syndrome (CRS) and immune effector cell associated neurotoxicity syndrome (ICANS) are …

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

E Bergsten, AC Horne, M Aricó… - Blood, The Journal …, 2017 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory
syndrome comprising familial/genetic HLH (FHL) and secondary HLH. In the HLH-94 study …

Histiocytic disorders

KL McClain, C Bigenwald, M Collin… - Nature Reviews …, 2021 - nature.com
The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …

Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial

A Ahmed, SA Merrill, F Alsawah… - The Lancet …, 2019 - thelancet.com
Background Hemophagocytic lymphohistiocytosis is a cytokine-driven inflammatory
syndrome that is associated with substantial morbidity and mortality. Overall survival in adult …

Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies

S Vakili-Samiani, AT Jalil, WK Abdelbasset… - DNA repair, 2021 - Elsevier
Hematologic malignancies include various diseases that develop from hematopoietic stem
cells of bone marrow or lymphatic organs. Currently, conventional DNA-damage-based …

[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

MV Maus, S Alexander, MR Bishop… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Immune effector cell (IEC) therapies offer durable and sustained remissions in significant
numbers of patients with hematological cancers. While these unique immunotherapies have …

cytokine storm syndrome: looking toward the precision medicine era.

EM Behrens, GA Koretzky - Arthritis & rheumatology, 2017 - search.ebscohost.com
The article focuses on cytokine storm syndrome which is a diverse set of conditions unified
by a clinical phenotype of systemic inflammation, multi-organ failure and hyperferritinemia …